.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 7,214,683

« Back to Dashboard

Claims for Patent: 7,214,683

Title:Compositions of descarboethoxyloratadine
Abstract:Methods are disclosed utilizing DCL, a metabolic derivative of loratadine, for the treatment of allergic rhinitis, and other disorders, while avoiding the concomitant liability of adverse side-effects associated with other non-sedating antihistamines.
Inventor(s): Aberg; A. K. Gunnar (Westborough, MA), McCullough; John R. (Worcester, MA), Smith; Emil R. (Shrewsbury, MA)
Assignee: Sepracor Inc. (Marlborough, MA)
Application Number:09/039,260
Patent Claims: 1. A pharmaceutical composition which comprises 0.1 to 10 mg of descarboethoxyloratadine, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

2. The pharmaceutical composition of claim 1, which is adapted for oral administration.

3. The pharmaceutical composition of claim 1, which is solid.

4. The pharmaceutical composition of claim 3, which is in the form of capsule or tablet.

5. The pharmaceutical composition of claim 1, wherein the carrier is selected from the group consisting of microcrystalline cellulose, starch, silicon dioxide, magnesium stearate, lactose, and a combination thereof.

6. The pharmaceutical composition of claim 5, wherein the carrier comprises microcrystalline cellulose.

7. The pharmaceutical composition of claim 5, wherein the carrier comprises starch.

8. The pharmaceutical composition of claim 5, wherein the carrier comprises silicon dioxide.

9. The pharmaceutical composition of claim 5, wherein the carrier comprises magnesium stearate.

10. The pharmaceutical composition of claim 5, wherein the carrier comprises lactose.

11. A pharmaceutical composition comprising: a) 0.1 mg to 10 mg descarboethoxyloratadine, or a pharmaceutically acceptable salt thereof; b) microcrystalline cellulose; and c) starch.

12. The pharmaceutical composition of claim 11, which further comprises silicon dioxide.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc